- Home
- THR vs PRTA Comparison
THR vs PRTA Comparison
Compare THR & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THR
- PRTA
- Stock Information
- Founded
- THR 1954
- PRTA 2012
- Country
- THR United States
- PRTA Ireland
- Employees
- THR N/A
- PRTA N/A
- Industry
- THR Industrial Machinery/Components
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- THR Energy
- PRTA Health Care
- Exchange
- THR Nasdaq
- PRTA Nasdaq
- Market Cap
- THR 960.7M
- PRTA 802.8M
- IPO Year
- THR 2011
- PRTA N/A
- Fundamental
- Price
- THR $31.19
- PRTA $14.44
- Analyst Decision
- THR Strong Buy
- PRTA Buy
- Analyst Count
- THR 1
- PRTA 7
- Target Price
- THR $38.00
- PRTA $57.67
- AVG Volume (30 Days)
- THR 222.1K
- PRTA 500.0K
- Earning Date
- THR 11-07-2024
- PRTA 11-12-2024
- Dividend Yield
- THR N/A
- PRTA N/A
- EPS Growth
- THR 4.78
- PRTA N/A
- EPS
- THR 1.29
- PRTA N/A
- Revenue
- THR $493,855,000.00
- PRTA $133,350,000.00
- Revenue This Year
- THR $7.99
- PRTA $60.63
- Revenue Next Year
- THR $7.58
- PRTA N/A
- P/E Ratio
- THR $24.24
- PRTA N/A
- Revenue Growth
- THR 3.94
- PRTA N/A
- 52 Week Low
- THR $23.76
- PRTA $13.22
- 52 Week High
- THR $35.93
- PRTA $41.55
- Technical
- Relative Strength Index (RSI)
- THR 68.30
- PRTA 37.20
- Support Level
- THR $29.79
- PRTA $13.22
- Resistance Level
- THR $30.96
- PRTA $18.60
- Average True Range (ATR)
- THR 1.22
- PRTA 1.05
- MACD
- THR 0.35
- PRTA -0.28
- Stochastic Oscillator
- THR 93.62
- PRTA 21.96
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).